Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
about
A constitutively nuclear form of NFATx shows efficient transactivation activity and induces differentiation of CD4(+)CD8(+) T cellsPartial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppressionSerological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.Expression of an antigen receptor on T cells does not require recombination at the immunoglobulin JH-C mu locusRadiation-induced lymphoblastic lymphomas/leukemias and sarcomas of mice express conserved, immunogenic 44-kilodalton oncofetal antigenMutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcomaCD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionCell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera.Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals.A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes.Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion.Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinations.Inhibition of B6RV2 leukemia growth by immunization with purified unique antigen.The roles of CD8+ and CD4+ cells in tumor rejection.
P2860
Q28216943-DA1629EE-F949-4420-AD48-1212447C7222Q28366018-F833E756-092E-4234-9182-101F24DE0D77Q30969714-87C38FA1-B99E-4F60-AF31-B73121AB160AQ34156338-488B7AD8-274D-42CC-BDA4-70204A96055FQ35385498-C3D43752-5C76-495A-B53A-A73732B22009Q35818293-64C4B304-7135-4386-A819-86EDD828968CQ36184608-9BFDFDD9-2E8A-4F67-A540-E4AFEA9221F4Q36230226-8AE5836C-631D-4A5F-BEDF-B54C08E2A257Q36349864-124133F4-E618-4BAD-9173-79322334610EQ36351610-A17A9EE8-B423-4ADC-952D-F1F9C7753E1DQ36363927-44A5422F-0101-47DB-9F4D-CFCDFFBA6761Q36390129-CEA2B043-61E7-4B7A-9FF9-B3057D68D89DQ39985987-8D04D266-6581-4B8F-A3B3-BD76D0CD6C4EQ40840298-259B314F-904C-4AD2-8F8A-1F4F19168DF2Q40864858-4F455325-D160-496F-94E6-3E4119F0D191Q41098584-05899D58-A14E-470B-80DD-330333AD752BQ44059979-D533CC21-E9D0-40F5-B548-25B7535E0E04Q44418597-746A8C95-74A0-405A-85D7-66F0EED18F88Q45231387-CF1E9586-A4BC-4CC3-B22E-1F8EBE2EFCECQ45887207-3D26F9F7-A917-467C-A0BB-FB79D179DBC2Q54965517-78EAA1B9-DE11-43B6-A217-035ACCC1AEB1Q55283530-4BAD64BD-E9A1-4042-8E7D-69416CB7FFF7
P2860
Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@en
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@nl
type
label
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@en
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@nl
prefLabel
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@en
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@nl
P2093
P2860
P356
P1476
Definition of a unique cell su ...... by cell-mediated cytotoxicity.
@en
P2093
P2860
P304
P356
10.1073/PNAS.76.7.3486
P407
P577
1979-07-01T00:00:00Z